Lightstone raises a fund of at least $200 million
SAN FRANCISCO, Sept 24
SAN FRANCISCO, Sept 24 (Reuters) - Lightstone Ventures, a firm formed by life-sciences partners at Morgenthaler Ventures and Advanced Technology Ventures, is raising a fund of at least $200 million.
The fund will focus on early-stage therapeutics, said a source, who did not want to be identified because of Securities and Exchange Commission regulations governing advertising of private funds. Those rules are currently being revised.
Last year, Morgenthaler and ATV told their investors they planned to spin off their life sciences teams and merge them, amid a challenging environment for life sciences. The partners will stay involved in the existing life-sciences and health investments at those firms, the person said, but new investments will be made from Lightstone.
Some venture capitalists see signs to be more positive about life sciences, including a handful of big acquisitions and a potentially speedier path to drug approval in some cases.
- Tweet this
- Share this
- Digg this
- South Africa admits error over 'schizophrenic' Mandela signer |
- Air strike kills 15 civilians in Yemen by mistake-officials
- UPDATE 2-Hilton Worldwide Holdings shares climb 9 percent in IPO
- UPDATE 2-Bangladesh executes Islamist leader, deadly clashes on streets
- Kiev protesters gather, EU and Putin joust
India's battle with inflation and weak economic growth became more challenging on Thursday with a sharp spike in the cost of food driving the highest retail price rises on record and a worse-than-anticipated contraction in industrial production. Full Article
Amount of dirty money leaving developing world jumped 14 pct in 2011 - report. Full Article